giovedì, 15 ottobre 2026

Notizie AIOM – anno XV n. 638

FDA’s ODAC Unanimously Recommends Biosimilar Versions of Bevacizumab and Trastuzumab

July 14, 2017 - On July 13, the U.S. Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC) unanimously recommended approval of biosimilar versions of bevacizumab and trastuzumab. In the morning session, ODAC members voted 17-0 in favor of approving ...
Leggi tutto

New CDC Report Shows Cancer Death Rates Are Higher in Rural America

July 13, 2017 - Despite decreases in cancer death rates nationwide, a new report from the Centers for Disease Control and Prevention (CDC) shows slower reduction in cancer death rates in rural America (a decrease of 1.0% per year) compared with urban America (a decrease ...
Leggi tutto

Contemporary Treatment Patterns and Outcomes for Clinical Stage IS Testicular Cancer

Controversy exists regarding the optimal management strategy for clinical stage IS seminomatous (SGCT) and nonseminomatous germ cell tumors (NSGCT) of the testis. To assess contemporary treatment patterns and outcomes for clinical stage IS testicular cancer. Using the National ...
Leggi tutto

Clinical utility of circulating DNA analysis for rapid detection of actionable mutations to select metastatic colorectal patients for anti-EGFR treatment

While tumor-tissue remains the ‘gold standard’ for genetic analysis in cancer patients, it is challenged with the advent of circulating cell-free tumor DNA (ctDNA) analysis from blood samples. Here, we broaden our previous study on the clinical validation of ...
Leggi tutto

14 luglio 2017 – Procedura di applicazione Managed Entry Agreement – medicinale Ipilimumab

Antiemetic Corticosteroid Rotation from Dexamethasone to Methylprednisolone to Prevent Dexamethasone-Induced Hiccup in Cancer Patients Treated with Chemotherapy: A Randomized, Single-Blind, Crossover Phase III Trial

To assess whether the rotation of dexamethasone to methylprednisolone decreases the intensity of dexamethasone-induced hiccup (DIH) in cancer patients treated with chemotherapy. Adult patients who experienced DIH within 3 days after the administration of dexamethasone as ...
Leggi tutto

XXXV CONFERENZA NAZIONALE DI CITOMETRIA Aggiornamenti e Innovazioni della Citometria nelle Applicazioni Cliniche e di Ricerca

Paestum (SA), 3 - 6 ottobre 2017 I Soci AIOM potranno usufruire della stessa quota d'iscrizione ridotta per i Soci GIC Bando per il Premio di Studio “Marcello Spanò” GIC 2017, 31^ edizione, dal titolo: “La Citometria nelle tesi sperimentali ed in ...
Leggi tutto

Dalla malattia a una nuova visione della vita

In viaggio per guarire è il progetto che ha ricevuto il primo Italian Teacher Prize, premio nazionale insegnanti indetto dal MIUR (Ministero dell’Istruzione, Università e Ricerca), coordinato dalla prof.ssa Anna Berenzi della sezione ospedaliera dell’I.I.S. ...
Leggi tutto

MammaPrint Test Addressed in ASCO Breast Cancer Guideline Update

July 11, 2017 - New recommendations on the use of the MammaPrint genomic test issued on July 10 will help guide decisions on adjuvant systemic therapy for women with early breast cancer. The recommendations update the ASCO 2016 clinical practice guideline on the use of biomarkers ...
Leggi tutto

FDA Grants Abemaciclib Priority Review for HR+/HER2- Breast Cancer

July 10, 2017 - The FDA has granted a priority review to a new drug application (NDA) for abemaciclib as a treatment for patients with advanced hormone receptor (HR)positive, HER2-negative breast cancer, according to Eli Lilly and Company, the manufacturer of the CDK4/6 ...
Leggi tutto